HIGHLIGHTS
- who: Mingli Zhong and collaborators from the University of Pretoria, South Africa have published the research work: A retrospective clinical study of dolutegravir- versus efavirenz-based regimen in treatment-nau00efve patients with advanced HIV infection in Nanjing, China, in the Journal: (JOURNAL) of May/31,/2022
- what: The aims of the study were (i) to compare virologic efficacy, immunologic response, and safety with 3DRs including EFV and DTG in ART-nau00efve PLWH with CD4+ T-cell counts and amp;lt;200 cells/mL and_(ii) to explore factors associated with immune recovery in ART-nau00efve . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.